Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHPS | P49366 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.94 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.94 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.94 |
| ▸ | MAOA | P21397 | 1/20 | 0.94 |
| ▸ | MAOB | P27338 | 1/20 | 0.94 |
| ▸ | BLM | P54132 | 1/20 | 0.74 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.74 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29454036 | 1.00 | DHPS (1.00) | DHPSCYP1A2ALOX15NFKB1MAOA | |
| SCHEMBL6698421 | 1.00 | DHPS (1.00) | DHPSCYP1A2ALOX15NFKB1MAOA | |
| SCHEMBL6700147 | 1.00 | DHPS (1.00) | DHPSCYP1A2ALOX15NFKB1MAOA | |
| SCHEMBL6693210 | 1.00 | DHPS (1.00) | DHPSCYP1A2ALOX15NFKB1MAOA | |
| Agmatine SCHEMBL195497 | 0.97 | — | — | |
| Agmatine SCHEMBL1738246 | 0.94 | CYP1A2 (0.94) | DHPSCYP1A2ALOX15NFKB1MAOA | |
| Sulfuric Acid SCHEMBL22440175 | 0.89 | BLM (0.96) | DHPSCYP1A2ALOX15NFKB1MAOA | |
| SCHEMBL689587 | 0.88 | — | — | |
| SCHEMBL1736310 | 0.88 | DHPS (0.78) | DHPSCYP1A2ALOX15NFKB1MAOA | |
| Bromide SCHEMBL11026850 | 0.86 | CYP1A2 (0.79) | DHPSCYP1A2ALOX15NFKB1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040092599-A1 | Production process of guanidine derivative containing amido group and salt thereof | AJINOMOTO CO., INC. (JP) | 2004-05-13 | — | — | US | disclosed |
| EP-1270552-A2 | Production process for a guanidine derivative containing an amido group and for a salt thereof | Ajinomoto Co., Inc. (JP) | 2003-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040092599-A1 | Production process of guanidine derivative containing amido group and salt thereof | FASN, GMPS, CEL | DHPS 586/4885CYP1A2 2242/4885ALOX15 320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.